Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| N-methylated xanthine derivatives | 4426 | 5634-34-4 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
None
None
None
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | R03DA10 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES Xanthines |
| MeSH PA | D001993 | Bronchodilator Agents |
| MeSH PA | D002317 | Cardiovascular Agents |
| MeSH PA | D014665 | Vasodilator Agents |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D018927 | Anti-Asthmatic Agents |
| MeSH PA | D019141 | Respiratory System Agents |
None
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Phosphodiesterase 4 | Enzyme | INHIBITOR | Ki | 4.25 | CHEMBL | CHEMBL | |||
| Adenosine receptor A1 | GPCR | ANTAGONIST | Ki | 9.22 | CHEMBL | CHEMBL | |||
| Adenosine receptor A2b | GPCR | ANTAGONIST | Ki | 5.57 | CHEMBL | CHEMBL | |||
| Adenosine A2 receptor | GPCR | ANTAGONIST | Ki | 4.85 | CHEMBL | CHEMBL | |||
| Phosphodiesterase 3 | Enzyme | INHIBITOR | CHEMBL | CHEMBL | |||||
| Adenosine receptor A2a | GPCR | ANTAGONIST | Ki | 9.22 | CHEMBL | CHEMBL | |||
| Adenosine receptor A3 | GPCR | ANTAGONIST | Ki | 7.85 | CHEMBL | ||||
| Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | Ki | 4.09 | CHEMBL | |||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Kinase | IC50 | 4.12 | CHEMBL | |||||
| Uncharacterized protein | Enzyme | Ki | 4.11 | CHEMBL | |||||
| Adenosine receptor A3 | GPCR | Ki | 4.07 | CHEMBL | |||||
| Adenosine receptor A1 | GPCR | Ki | 5.42 | CHEMBL | |||||
| Adenosine receptor A1 | GPCR | Ki | 5.01 | CHEMBL | |||||
| Adenosine A2 receptor | GPCR | Ki | 5.88 | CHEMBL | |||||
| Adenosine A2b receptor | GPCR | Ki | 4.82 | CHEMBL | |||||
| Adenosine receptor | GPCR | Ki | 4.70 | CHEMBL | |||||
| Heart phosphodiesterase | Enzyme | IC50 | 4.04 | CHEMBL | |||||
| Adenosine A2a receptor | GPCR | Ki | 4.89 | CHEMBL | |||||
| Adenosine receptor A1 | GPCR | Ki | 6.15 | CHEMBL | |||||
| Adenosine receptor A2a | GPCR | Ki | 5.17 | CHEMBL |
| ID | Source |
|---|---|
| D02884 | KEGG_DRUG |
| C3652921 | UMLSCUI |
| CHEBI:750615 | CHEBI |
| CHEMBL2104089 | ChEMBL_ID |
| DB13812 | DRUGBANK_ID |
| C006485 | MESH_SUPPLEMENTAL_RECORD_UI |
| 21850 | PUBCHEM_CID |
| 006001 | NDDF |
| 7302008 | SNOMEDCT_US |
| VOU5V0B772 | UNII |
None